Browsing Internal Medicine by Author "Ker, James A."

Browsing Internal Medicine by Author "Ker, James A."

Sort by: Order: Results:

  • The first presentation of cardiovascular disease 
    Ker, James A. (New Media Publishing, 2016-10)
    For decades there has been an emphasis on the first presentation of cardiovascular disease (CVD) as a myocardial infarction (MI) and stroke and subsequently the effort in prevention was on these two conditions. This strategy ...
  • Frequency of the metabolic syndrome in screened South African corporate executives 
    Ker, James A.; Rheeder, Paul; Van Tonder, R. (Clinics Cardiv, 2007-01)
    The aim of the study was to determine the frequency of the metabolic syndrome in a specific group of people. The ATP III criteria were used to identify the metabolic syndrome in a group of 1 410 corporate executives belonging ...
  • The global impact of hypertension 
    Ker, James A. (New Media Publishing, 2016-03)
    It is estimated that hypertension is the cause of about 50% of heart disease, stroke and heart failure (HF), 18% of deaths overall and more than 40% of deaths in people with diabetes. In addition, hypertension is a leading ...
  • Heart failure 
    Ker, James A. (Medpharm Publications, 2010-05)
    Heart failure is a clinical syndrome that can result from any structural or functional cardiac disorder that impairs the performance of the ventricle: either to eject blood (systolic dysfunction) [or reduced ejection ...
  • The heart in diabetes 
    Ker, James A. (Clinics Cardiv, 2010-06)
    Diabetes mellitus is associated with a two- to four-fold increased risk of coronary artery disease, and in diabetic people, about two-thirds of deaths are cardiovascular (ischaemic heart disease, congestive heart failure ...
  • Higher protein intake reduce risk of hypertension 
    Ker, James A. (New Media Publishing, 2015-11)
    Hypertension remains the most important treatable risk factor for cardiac disease worldwide.In the Dietary Approaches to Stop Hypertension (DASH) trials the importance of diet patterns to reduce blood pressure (BP), were shown.
  • Hypercholesterolaemia and coronary risk 
    Ker, James A. (New Media Publishing, 2016-05)
    Studies have shown that only 10.6% of people with hypercholesterolaemia receive a statin or treatment. There is a within-person variability of cholesterol measurements and therefore a one-time measurement of cholesterol ...
  • Hypertension 
    Ker, James A. (South African Academy of Family Practice/Primary Care, 2011-07)
    Approximately one in four adults has hypertension, a prevalence that increases with age and may reach to two out of three adults older than 70 years of age. In the Framingham Heart Study 65-75% of hypertension in the elderly ...
  • Hypertension and sexual dysfunction 
    Ker, James A. (South African Academy of Family Practice/Primary Care, 2012)
    No abstract available.
  • Inflammation of the heart 
    Ker, James A. (New Media Publishing, 2015-10)
    Endocarditis is best viewed as an inflammation of the endocardial surface of the heart which includes the heart valves, mural endocardium and the endocardial surface that covers implanted material (prosthetic valves, ...
  • Is it really a benign condition? 
    Ker, James A. (Media 24, 2015-06)
    Whitecoat hypertension (or isolated clinic hypertension) is currently defined as elevated blood pressure (BP) when measured in the clinic, but normal BP when assessed away from the medical environment.
  • Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension? 
    Ker, James A. (Medpharm Publications, 2015)
    The renin-angiotensin system (RAS) and angiotensin II, in particular, play a central role and have been implicated in the spectrum of cardiovascular disease (CVD), beginning with hypertension, diabetes mellitus, ...
  • LDL-cholesterol reduction vs LDL target level : which is more important? 
    Ker, James A. (New Media Publishing, 2016-07)
    There is enough documented evidence of the role of low-density-lipoprotein cholesterol (LDL-C) in the pathogenesis of atherosclerotic cardiovascular disease (CVD).
  • Management issues in hypertensive diabetics 
    Ker, James A. (2006-11)
    This article discusses seven issues in the management of hypertension in diabetic patients, namely the importance of blood pressure control, optimal blood pressure control levels, the importance of blocking the renin-angiotensin ...
  • MI management considerations in the elderly 
    Ker, James A. (New Media Publishing, 2019-04)
    One of the acknowledged problems is that the elderly has not been represented enough in randomised clinical trials of myocardial infarction (MI) management. Now, 40 years since the first percutaneous coronary ...
  • The MOGE(S) system explained 
    Ker, James A. (Media 24, 2015-08)
    In a standard textbook of medicine, the first step in the evaluation of cardiomyopathy is to make the distinction between ischaemic heart disease (IHD) as the cause of cardiomyopathy as opposed to nonischaemic causes of ...
  • A new phenotypic marker of hypertrophic cardiomyopathy 
    Ker, James A. (Elsevier, 2014-11)
    No abstract available.
  • Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus 
    Kgomo, Mpho K.; Mokoena, Taole; Ker, James A. (BMJ Publishing Group, 2017)
    INTRODUCTION : Squamous cell carcinoma of the oesophagus is a common cancer among South Africans. Due to the absence of effective screening and surveillance programme for early detection and late presentation, ...
  • NT-proBNP : when is it useful in obstetric medicine? 
    Ker, James A.; Soma-Pillay, Priya (Sage, 2018-03)
    Pregnancy, viewed as a stress test of the haemodynamic system, may unmask underlying cardiac disease. Pregnancy may also induce de novo cardiac disease. N-terminal pro brain-type natriuretic peptide (NT-proBNP) is a useful ...
  • Obstructive sleep apnoea 
    Ker, James A. (Media 24, 2015-06)
    Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is one of the most important medical conditions documented in the last 50 years. OSAHS is a major cause of morbidity and a significant cause of premature death.